CDC and FDA response to risk of confusion in dosing Tamiflu oral suspension.
Budnitz
Daniel S
DS
Lewis
Linda L
LL
Shehab
Nadine
N
Birnkrant
Debra
D
D000284:Administration, Oral; D000998:Antiviral Agents / Q000008:administration & dosage*; D002487:Centers for Disease Control and Prevention, U.S.; D054796:Drug Dosage Calculations; D004348:Drug Labeling / Q000592:standards*; D006801:Humans; D008508:Medication Errors / Q000517:prevention & control*; D053139:Oseltamivir / Q000008:administration & dosage*; D014481:United States; D014486:United States Food and Drug Administration
D000998:Antiviral Agents; D053139:Oseltamivir